Cargando…
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
BACKGROUND: Methylation of promoter region is the major mechanism affecting gene expression in tumors. Recent methylome studies of brain tumors revealed a list of new epigenetically modified genes. Our aim was to study promoter methylation of newly identified epigenetically silenced genes together w...
Autores principales: | Skiriute, Daina, Vaitkiene, Paulina, Saferis, Viktoras, Asmoniene, Virginija, Skauminas, Kestutis, Deltuva, Vytenis Pranas, Tamasauskas, Arimantas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404983/ https://www.ncbi.nlm.nih.gov/pubmed/22672670 http://dx.doi.org/10.1186/1471-2407-12-218 |
Ejemplares similares
-
GATA4 and DcR1 methylation in glioblastomas
por: Vaitkienė, Paulina, et al.
Publicado: (2013) -
High level of Sema3C is associated with glioma malignancy
por: Vaitkienė, Paulina, et al.
Publicado: (2015) -
Significance of Amphiregulin (AREG) for the Outcome of Low and High Grade Astrocytoma Patients
por: Steponaitis, Giedrius, et al.
Publicado: (2019) -
Glioma Malignancy-Dependent NDRG2 Gene Methylation and Downregulation Correlates with Poor Patient Outcome
por: Skiriutė, Daina, et al.
Publicado: (2014) -
Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma
por: Steponaitis, Giedrius, et al.
Publicado: (2016)